The wet form of age-related macular degeneration (AMD) is currently treated with eye drugs that are blockbuster sellers. Opthea Limited is developing a wet AMD drug that goes after different targets and the biotech struck a pair of financing deals that provide it with the cash for pivotal tests that could show how well its approach works.
/PRNewswire/ Biosimilars are biopharmaceutical products that are nearly identical copies of drugs that have previously been licensed (reference products),.